Search results

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

Athebio develops ultra-stable biotherapeutics using proprietary Athebody® DARPin molecules with high affinity and specificity. We partner on radiotherapeutics, T cell engagers, targeted delivery (LNP/AAV/oligo) and affinity ligands, enabling breakthrough therapeutic strategies.

Betta Scientific is a Life Sciences consultancy. We support start-ups and established companies in entering international markets. Our clients rely on us to design and execute global go-to-market strategies, build international distribution networks, and accelerate revenue generation across borders.

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years.

Our comprehensive services for early phase drug development, enables you to get your product to market faster. Our state-of-the-art Zürich laboratory focuses on science, compliance and speed to deliver high-quality data analysis. We apply our 40+ years of experience to exceed your expectations.

Cellerys AG is a clinical stage biotechnology company, developing immune tolerance therapeutics for the treatment of multiple sclerosis (MS). Antigenic peptides identified from MS patients are coupled to autologous red blood cells which, when reinfused, restore immune tolerance. in 2021 the company entered a

ClearView helps life science clients build robust strategies. Our work spans asset, franchise, and corporate-level strategy across therapeutic areas, lifecycle stages, and regions of the world.

Caidya is a multi-therapeutic clinical research organization serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, we offer a wide range of clinical services and vast therapeutic expertise.

CMC & More delivers hands-on CMC, regulatory, and quality expertise for biotech and pharma. We bridge discovery to first-in-human trials and beyond with GMP-compliant CMC strategies that derisk development and transform complex products into approval-ready assets.

Delta Medical, based in Zurich, specializes in pharmaceutical marketing, distribution, regulatory affairs, market access, and pharmacovigilance, serving Ukraine and Eurasian markets with tailored commercialization solutions and strategic partnerships.

DiNAQOR has developed a proprietary technology platform and manufacturing capabilities designed to overcome the challenges and limitations of early-stage gene therapy development.

DKSH is a global distribution and strategic solutions partner for life science and industrial specialties. We provide innovative and sustainable pharmaceutical and biopharmaceutical ingredients to manufacturers across Asia, Europe, and North America.

DrM Group (Dr. Mueller AG) designs and manufactures advanced filtration systems, vibratory mixers, and single-use technologies for solid/liquid separation and processing. Headquartered in Switzerland, we serve the biotech, pharmaceutical, chemical, and food industries worldwide.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.

Eviden is an Atos business that brings together its digital, cloud and big data & security business lines. It will be a global leader in data-driven, trusted and sustainable digital transformation.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

Fortrea (formerly Labcorp Drug Development/ Covance) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We provide phase I-IV clinical trial management, clinical pharmacology, technology enabled trial solutions and post-approval services.

Future Health Pharma GmbH represents companies in Switzerland and distributes and markets their products in CH, UK and EU. We act as Marketing Authorisation Holder or establish their affiliate in CH and EU. We also hold an establishment license to handle controlled substances (narcotics) & vaccines.

GlycoEra is developing biologics to selectively degrade autoimmune disease causing circulating proteins rapidly, selectively, and deeply while avoiding broader dampening of the immune system. This offers many potential benefits over existing broad-spectrum immune-suppressing therapies.

GMP4U is offering engineering and consulting services for the life sciences industry. As experts in qualification and validation, we support our clients in ensuring GMP compliance for production equipment, laboratory instruments, and information management systems.

Founded in 2012, headcount is a Swiss recruitment agency specializing in Biotech, Medtech, Pharma, and Digital Health. We combine scientific expertise with recruitment excellence to connect top talent with leading companies, ensuring a perfect cultural and professional fit.

ImmunOs Therapeutics AG is a biotechnology company focused on discovering and developing novel human immunomodulatory proteins for cancer with a specific role in innate immunity.

InterAx developed a unique drug discovery platform integrating biochemistry, cellular pathways mathematical modelling and AI to decode the cellular communication language. This novel approach enables the rapid and precise identification of differentiated effective and safe candidates.

Jantar is a clinical R&D company in the field of chronic rhinosinusitis. Its product is a nasal spray of dicholine succinate. Clinical efficacy has been demonstrated by well-documented case studies which showed that the drug relieves all symptoms of the disease. A PCT patent has been filed.

LubioScience is the biggest lifescience reagents & services platform in Switzerland. Representing some of the world’s most recognized brands, we provide over 5 million products from more than 120 suppliers and pride ourselves in working with most Swiss biotech companies & start-ups.

Whatever your level of maturity regarding the valorization of data in your company, our Luciders are your trusted advisors to design and implement a data roadmap. We will work closely with your different business units to explore how data, advanced analytics, AI and ML can solve complex challenges.

Mabylon is a clinical-stage company leading innovation in human-derived antibody therapeutics for severe allergies, inflammation, and neurological disorders. MY006, our first-in-class multi-specific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

MD Bioproducts, with over 30 years of experience, is a worldwide manufacturer and supplier of high-quality antibodies, reagents, peptides, assays, and disease-induction reagents supporting research in arthritis, autoimmune diseases, immunology, inflammation, neurology, metabolism, and oncology.

MedScienceSwiss AG is developing the technology of the future for the treatment of resistant bacteria and has the potential to significantly reduce the number of deaths in hospitals due to nosocomial infections and save resources and money, payers & Nat. Health services. Visit our poster Nr 25 at the Swis

Memo Therapeutics AG develops therapeutic antibodies for viral infections and cancer. Lead asset potravitug targets BKV in kidney transplant recipients; Phase II SAFE KIDNEY data, presented in Nov 2025, support a planned Phase III start in 2026. MTx is also building an oncology discovery pipeline.

MetrioPharm AG, a clinical stage biopharmaceutical development company based in Zurich with a subsidiary in Berlin, Germany, has developed a platform of small molecule drug candidates (oral and i.v.) which targets the modulation of immune cell metabolism without suppressing the immune system.

MUVON is a Swiss, clinical stage biotech company with the goal of revolutionizing the treatment of diseases caused by muscle damage or degradation through the use of the patients' own cells. Our initial area of focus is the treatment of stress urinary incontinence in women (PhII completed)

At Navignostics we characterize tumors using spatial single-cell proteomics. We use unique capabilities to identify a cancer treatment that will optimally fight a tumor. We accelerate cancer drug development by providing key insights into drug mechanisms and tumor features to pharma companies.

There is a new kit on the block. Swiss start-up NEMIS Technologies AG specialises in the development of simple, safe, and on-site pathogen testing solutions. Its detection test for Listeria monocytogenes is already commercially available in Switzerland, France, and Spain.

NexMR offers the first technological solutions to do drug discovery on a benchtop NMR spectrometer without compromising speed and data quality.

The Nikon Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and academia with industry leading microscope-based imaging solutions. In addtion the Nikon BioImaging Lab, is a CRO that provides microscope-based imaging and analysis services.

Our goal is to deliver innovations in health care through cutting-edge tech and research, addressing challenges in antimicrobial therapies to improve patient outcomes. We are committed to delivering superior treatments that promote healing and improve quality of life globally.

As Swiss branch of Promega Corp, Promega AG offers local scientific expertise for 4000+ products covering genomics, proteomics and cell analysis. Promega is a global leader in providing innovative solutions for drug discovery, basic research, human identification, diagnostics and food/water testing.

Real Chemistry is a global healthcare communications network accelerating the journey from molecule to market. We integrate deep scientific and medical expertise, advanced AI, data-driven strategy, and creative excellence to deliver evidence-based engagement and measurable commercial impact.

Tepthera is a spin off from the ETH Zurich focusing on product development in the field of cancer immunotherapy, autoimmune- and infectious diseases.

Santersus AG is an innovative Therapeutic Apheresis company focused on using our patented technology for the cleansing of patient blood of cell free DNA and neutrophil extracellular traps (NETs) looking to revolutionize how we can control the human immune and inflammatory response to disease.

The grow Foundation provides small and large Life Sciences companies ready-to-use laboratories, offices, piloting and production facilities in Wädenswil/Horgen, in size ranging from a few working benches to several thousand m2.

Swiss Consultant-Network GmbH is developing a new data management system that can be used as a framework for the integration of heterogeneous data in the field of biological research and development. We offer our customers IT engineers, who have in-depth knowledge of computer science disciplines.

Switzerland Global Enterprise (S-GE) links companies, experts and public organisations globally, thus facilitating efficient promotion of foreign trade. Apart from export promotion, S-GE is responsible for promoting Switzerland as a business location abroad.

SYDRA AG (Zurich) is a longevity biotech using a phenotype-first, AI-assisted “Hit-to-Target” early drug discovery platform. We discover small molecules (geroprotectors), validate in vivo (worms – aged mice), then map MoA to build partner-ready drug assets; plus science-backed supplements.

Synple Chem was founded to develop new easy to use automated laboratory equipment for chemistry research labs.

Tandem Therapeutics (Spin-off ETH Zurich & PSI) is tackling the growing unmet medical need in treating fibrosis with precision extracellular matrix targeting. Our novel peptide drug conjugates selectively target mechanical changes in the fibrotic extracellular matrix to potentially halt progression.

therainnova AG provides strategic and operational regulatory affairs consulting for the biopharmaceutical industry in Europe. With expert leadership and a strong partner network, we offer end-to-end regulatory support, including due diligence, to maximize portfolio value.

Topadur Pharma AG, founded in 2015 in Schlieren, is a clinical-stage biopharmaceutical company. Leveraging its proprietary DualTOP™ platform, Topadur develops dual-acting molecules that restore cGMP levels, repairing microcirculation, promoting tissue regeneration, and addressing oxygen deficiency.

TransHeps specializes in iDILI causality assessments, supporting drug developers in clinical trials and managing drug-induced liver injuries. Leveraging cutting-edge expertise, we provide reliable solutions to improve drug safety and accelerate pharmaceutical innovations.

Ultimate Medicine is a Swiss preclinical biotech focused on preserving independence and quality of life for patients with Alzheimer's disease and other dementias.

VACCENTIS AG is a Zurich-based investment company focused on the biotech and pharmaceutical sector. The entire research, production and sales activities are carried out by two highly specialized subsidiaries, VCC MEDICAL and FBM- Pharma, which focus on special methods of personalized medicine

Venture Valuation specializes in independent assessments and valuations of companies/products in biotech/life sciences and runs the business development database Biotechgate with global licensing deals and opportunities www.biotechgate.com and Biotechgate Digital Partnering www.digitalpartnering.com

Watson-Marlow is a specialist manufacturer of pumps and tubing, fluid path components and single-use technology for GMP regulated industries. A portfolio of products and assembly design capabilities allows WMFTS to provid accuracy, reliability, and sterility in all fluid handling applications.

WittKieffer is a top 10 executive search and leadership advisory firm exclusively specialised in life sciences organizations operating at the intersection of academia, science, and healthcare.

Wyss Zurich is a joint accelerator of ETH & University of Zurich. Our mission is to drive the clinical translation of outstanding scientific discoveries into new therapies for patients and innovations in the fields of regenerative medicine and robotics, and hybrid technologies in these fields.

Xlife Sciences is a publicly listed life sciences incubator and accelerator. Xlife is focused on the value development and commercialization of promising research projects from universities and other research institutions. The goal is to bridge research and development to healthcare markets.